Chronic ulcer is one of the most common suffered diseases in the clinic of plastic surgery. Effective therapeutics is currently not available due to the largely undefined pathological processes. It is proved that miRs play important roles in wound healing, with miR-26a found as a new target for both inhibiting angiogenesis and cell migration. This promoted us to further study the role of miR-26a wound healing. We propose that inhibiting miR-26a both promotes angiogenesis and cell migration in the treatment of wound healing. To test this hypothesis, we will first transfer miR-26a to human umbilical vein endothelial cells(HUVEC)and cultured human keratinocytes (HaCaT), observe the consequent effect on cell proliferation and migration, and detect the relative cytokines of PTEN/Akt/VEGF and PTEN/Akt/β-catenin pathways. Mice wound healing models will also be established to detect the effect of miR-26a on wound healing and its relative cytokines in vivo. The successful completion of this project may provide insight into the role and mechanism of miR-26a on endothelial cells and keratinocytes,and provides a new multiple functional target for promoting wound healing.
慢性难治性创面是临床上常见的疾病,其发病机理复杂,目前临床治疗效果有限。现已发现小分子RNA (miR)在创面愈合过程中扮演着重要的角色,而miR-26a 是新发现的同时具有血管生成抑制作用和细胞迁移抑制作用的miR。我们假设miR-26a抑制剂可通过PTEN促进创面的血管再生和细胞迁移,成为创面愈合过程中的一个多功能因子。拟通过构建慢病毒miR-26a载体转染人脐静脉内皮细胞(HUVEC)和人永生化表皮细胞(HaCaT),观察其对细胞生长增殖的影响,检测PTEN/Akt/VEGF 和PTEN/Akt/β-catenin信号通路相关因子的表达。并通过建立小鼠全层皮肤缺损创面模型,观察miR-26a干预后的创面愈合情况及通路相关因子的表达。本研究的实施有助于阐miR-26a影响血管内皮细胞和表皮细胞生长,增殖和爬行的作用和机理,为创面治疗提供新的靶点。
MicroRNAs在不同的生理和病理过程中扮演着重要的角色,包括发育,分化,增殖,凋亡,与肿瘤的发生,其调节包括细胞分化,复制,迁移的不同的细胞过程中,细胞凋亡。miR-26a 是新发现的具有血管生成抑制作用的miR,常作为肿瘤抑制基因存在。本研究采用慢病毒感染技术,建立mir-26a过表达HaCaT细胞模型,结果发现转染miR-26a抑制剂后HaCaT细胞增殖能力、迁移能力较转染miR-26a促进剂细胞和空白组明显增强,并且证明了这一改变可能是通过PTEN/AKT /GSK3β通路相关因子的调控来实现的。研究观察低氧对人脐静脉血管内皮细胞(HUVEC)mir-26a及PTEN/AKT/VEGF通路相关因子表达的影响,结果发现低氧抑制HUVEC miR-26a的表达并继发下游PTEN/AKT/VEGF因子的序贯反应,可作为创面改善缺血状态治疗的新靶点。研究制作野生型和糖尿病小鼠全层皮肤缺损创面模型,观察局部应用miR-26a抑制剂对小鼠创面愈合的影响;发现miR-26a抑制剂能诱导创面血管新生和细胞增生,从而促进创面愈合。
{{i.achievement_title}}
数据更新时间:2023-05-31
MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway
Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway
Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy
MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A
Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2
局部应用胰岛素调控创面巨噬细胞表型改善糖尿病创面愈合机制研究
烧伤创面愈合基因调控和相关新基因的研究
REST调控角质形成细胞增殖/分化的平衡在创面愈合中的作用及机制研究
Rac1蛋白调控表皮干细胞促进创面愈合及其机制初探